|
Market Closed -
TEL AVIV STOCK EXCHANGE
11:47:02 16/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 2,443.00 ILa | +0.33% |
|
-1.01% | +8.10% |
| 10-06 | Kamada Launches Ustekinumab, Enoxaparin Biosimilars in Israel | MT |
| 10-06 | Kamada Ltd. Announces Expansion of Biosimilars Portfolio with Launch of Two Additional Products in Israel | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KAMADA LTD. | Biopharmaceuticals | +0.33% | -1.01% | +8.10% | +12.43% | +43.12% | 455M |  |  |  |
- Stock Market
- Stocks
- KMDA Stock
- Charts Kamada Ltd.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
